Literature DB >> 31310416

Safety and efficacy of leadless pacemaker retrieval.

Jianwen Li1, Wen-Bo Hou1, Ming-Kun Cao1, Wen-Xiu Zhou1, Yan Wang1, Yi Fang1, Chao Zhou1, Yu-Xia Yin1, Egon S Toft2, Hai-Jun Zhang1,3,4.   

Abstract

BACKGROUND AND OBJECTIVES: The success rate of leadless cardiac pacemaker (LP) retrieval remains a major concern for this disruptive technology. The present paper performed a systematic review of the safety and feasibility of the retrieval of LPs.
METHODS: Primary publications that performed LP retrieval were collected and included five animal experiments and two worldwide retrieval experiences in human. The procedural details, such as indication, days post implantation, extraction success rate, and complications, were described. The present paper analyzed factors affecting the retrieval and management of the nonfunctional devices.
RESULTS: Retrieval animal models was possible at least up to 2.5 years post implantation, and data from humans suggest that removal of a device that was implanted longer (eg, 4 years and 9 months for Nanostim; 4 years for Micra) could be performed within a reasonable safety profile. The fixed mechanism, implant site, and encapsulation of the LP systems may affect the retrieval process.
CONCLUSIONS: A high success rate in the relatively chronic retrieval of LPs was demonstrated, which promotes the extensive use of these devices in the treatment arrhythmia in the future.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  device life-cycle management; leadless cardiac pacemaker; retrieval; safety and efficacy

Year:  2019        PMID: 31310416     DOI: 10.1111/jce.14076

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  1 in total

1.  Simultaneous infection of abandoned leads and newly implanted leadless cardiac pacemaker: Why did this occur?

Authors:  Ayako Okada; Morio Shoda; Hiroaki Tabata; Hideki Kobayashi; Wataru Shoin; Takahiro Okano; Koji Yoshie; Ken Kato; Hirohiko Motoki; Koichiro Kuwahara
Journal:  J Cardiol Cases       Date:  2020-10-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.